Matthew Plavan
2020 - Arcadia Biosciences
In 2020, Matthew Plavan earned a total compensation of $794.1K as President and Chief Executive Officer at Arcadia Biosciences, a 37% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $98,506 |
|---|---|
| Option Awards | $325,642 |
| Salary | $370,000 |
| Total | $794,148 |
Plavan received $370K in salary, accounting for 47% of the total pay in 2020.
Plavan also received $98.5K in non-equity incentive plan and $325.6K in option awards.
Rankings
In 2020, Matthew Plavan's compensation ranked 9,529th out of 13,090 executives tracked by ExecPay. In other words, Plavan earned more than 27.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,529 out of 13,090 | 27th |
Division Agriculture, Forestry, And Fishing | 31 out of 54 | 43rd |
Major group Agricultural Production Crops | 19 out of 32 | 41st |
Source: SEC filing on April 20, 2021.
Plavan's colleagues
We found three more compensation records of executives who worked with Matthew Plavan at Arcadia Biosciences in 2020.
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019